Propofol vs midazolam for ICU sedation: A Canadian multicenter randomized trial

Richard I. Hall, Dean Sandham, Pierre Cardinal, Martin Tweeddale, David Moher, Xiaohua Wang, Aslam H. Anis, David Stewart, Hugh Devitt, Craig Guenther, Mauricio Calero, Hector Leon

Résultat de recherche: Articleexamen par les pairs

145 Citations (Scopus)

Résumé

Study objectives: To determine whether sedation with propofol would lead to shorter times to tracheal extubation and ICU length of stay than sedation with midazolam. Design: Multicenter, randomized, open label. Setting: Four academic tertiary-care ICUs in Canada. Patients: Critically ill patients requiring continuous sedation while receiving mechanical ventilation. Interventions: Random allocation by predicted requirement for mechanical ventilation (short sedation stratum, < 24 h; medium sedation stratum, ≥ 24 and < 72 h; and long sedation stratum, ≥ 72 h) to sedation regimens utilizing propofol or midazolam. Measurements and results: Using an intention-to-treat analysis, patients randomized to receive propofol in the short sedation stratum (propofol, 21 patients; midazolam, 26 patients) and the long sedation stratum (propofol, 4 patients; midazolam, 10 patients) were extubated earlier (short sedation stratum: propofol, 5.6 h; midazolam, 11.9 h; long sedation stratum: propofol, 8.4 h; midazolam, 46.8 h; p < 0.05). Pooled results showed that patients treated with propofol (n = 5 46) were extubated earlier than those treated with midazolam (n = 53) (6.7 vs 24.7 h, respectively; p < 0.05) following discontinuation of the sedation but were not discharged from ICU earlier (94.0 vs 63.7 h, respectively; p = 0.26). Propofol-treated patients spent a larger percentage of time at the target Ramsay sedation level than midazolam-treated patients (60.2% vs 44.0%, respectively; p < 0.05). Using a treatment-received analysis, propofol sedation either did not differ from midazolam sedation in time to tracheal extubation or ICU discharge (sedation duration, < 24 h) or was associated with earlier tracheal extubation but longer time to ICU discharge (sedation duration, ≥ 24 h, < 72 h, or ≥ 72 h). Conclusions: The use of propofol sedation allowed for more rapid tracheal extubation than when midazolam sedation was employed. This did not result in earlier ICU discharge.

Langue d'origineEnglish
Pages (de-à)1151-1159
Nombre de pages9
JournalChest
Volume119
Numéro de publication4
DOI
Statut de publicationPublished - avr. 2001
Publié à l'externeOui

Note bibliographique

Funding Information:
This research was supported by Zeneca Pharma Inc. Canada. Dr. Hall has received consultation fees from Zeneca Pharma Inc. and Hoffman-LaRoche Limited. He has no equity interest in either company. Drs. Sandham, Cardinal, Tweeddale, and Anis, and Mr. Moher and Mrs. Wang have no financial relationship with either company.

ASJC Scopus Subject Areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

PubMed: MeSH publication types

  • Clinical Trial
  • Comparative Study
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

Empreinte numérique

Plonger dans les sujets de recherche 'Propofol vs midazolam for ICU sedation: A Canadian multicenter randomized trial'. Ensemble, ils forment une empreinte numérique unique.

Citer